Expert Opinion on Investigational Drugs, Volume 26, Issue 12 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 26, Issue 12 (2017)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Volume 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Editorial
Investigational PD-1 inhibitors for advanced non-small lung cancer: new players in a shifting paradigm
Sassine Ghanem, Gautam Kishore Valecha, Sami Hossri, Uroosa Ibrahim & Jean Paul Atallah
Pages: 1317-1319
Published online: 24 Oct 2017
First Page PreviewforInvestigational PD-1 inhibitors for advanced non-small lung cancer: new players in a shifting paradigm | Full Text | References | PDF (823.1 KB)
  • 1821 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Glutamate receptor antagonists with the potential for migraine treatment
Anna Ferrari, Cecilia Rustichelli & Carlo Baraldi
Pages: 1321-1330
Published online: 27 Oct 2017
AbstractforGlutamate receptor antagonists with the potential for migraine treatment | Full Text | References | PDF (873.7 KB)
  • 352 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Phase I and II clinical trials for the mucopolysaccharidoses
Fabiano Poswar, Guilherme Baldo & Roberto Giugliani
Pages: 1331-1340
Published online: 31 Oct 2017
AbstractforPhase I and II clinical trials for the mucopolysaccharidoses | Full Text | References | PDF (783.6 KB)
  • 470 Views
  • 14 CrossRef citations
  • 0Altmetric
Review
Directing the use of DDR kinase inhibitors in cancer treatment
Inger Brandsma, Emmy D.G. Fleuren, Chris T. Williamson & Christopher J. Lord
Pages: 1341-1355
Published online: 14 Oct 2017
AbstractforDirecting the use of DDR kinase inhibitors in cancer treatment | Full Text | References | PDF (1.6 MB)
  • 1139 Views
  • 68 CrossRef citations
  • 0Altmetric
Review
CDK4/6 blockade in breast cancer: current experience and future perspectives
Dimitrios Zardavas, Noam Pondé & Konstantinos Tryfonidis
Pages: 1357-1372
Published online: 23 Oct 2017
AbstractforCDK4/6 blockade in breast cancer: current experience and future perspectives | Full Text | References | PDF (1.2 MB)
  • 864 Views
  • 19 CrossRef citations
  • 0Altmetric
Review
Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
André J. Scheen, Nicolas Paquot & Pierre J. Lefèbvre
Pages: 1373-1389
Published online: 26 Oct 2017
AbstractforInvestigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes | Full Text | References | PDF (1.6 MB)
  • 1002 Views
  • 60 CrossRef citations
  • 0Altmetric
Review
BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations
Mark C. Markowski, Angelo M. De Marzo & Emmanuel S. Antonarakis
Pages: 1391-1397
Published online: 27 Oct 2017
AbstractforBET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations | Full Text | References | PDF (887.2 KB)
  • 700 Views
  • 24 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Vedroprevir in the management of hepatitis C virus infection
Ameer Abutaleb & Shyamasundaran Kottilil
Pages: 1399-1402
Published online: 26 Oct 2017
AbstractforVedroprevir in the management of hepatitis C virus infection | Full Text | References | PDF (384.8 KB)
  • 106 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis
Masutaka Furue, Takafumi Kadono, Gaku Tsuji & Takeshi Nakahara
Pages: 1403-1408
Published online: 31 Oct 2017
AbstractforTopical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis | Full Text | References | PDF (566.5 KB)
  • 516 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles